Specify a stock or a cryptocurrency in the search bar to get a summary
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
688336Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, a biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of antibody drugs in China. Its products include YISAIPU, a tumor necrosis factor inhibitor for rheumatism; Xenopax, a recombinant humanized anti-CD25 monoclonal antibody injection; Cipterbin, an anti-HER2 monoclonal antibody. The company is also developing products for autoimmune diseases, tumors, and other diseases. The company was founded in 2002 and is based in Shanghai, China. Address: No. 399, Libing Road, Shanghai, China, 201203
Analytics
WallStreet Target Price
187.61 CNYP/E ratio
41.6102Dividend Yield
0.36 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 688336
Dividend Analytics 688336
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 688336
Stock Valuation 688336
Financials 688336
Results | 2019 | Dynamics |